United States · FDA National Drug Code directory
Lyleq
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50102-300_ffb8f5fe-9e1a-4ca9-adc9-181093af01b9
- Product NDC
- 50102-300
- Form
- TABLET
- Composition / generic term
- NORETHINDRONE
- Labeler
- Afaxys Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160923
- Source listing expiry
- 20261231
Source-listed ingredients
- NORETHINDRONE — .35 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 PACKAGE in 1 CARTON (50102-300-13) / 1 BLISTER PACK in 1 PACKAGE (50102-300-11) / 28 TABLET in 1 BLISTER PACK (50102-300-01) · 50102-300-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →